by James Rudge, PhD, Technical Director, Neoteryx | 3 min read
An article published by Nick Verougstraete and Christophe P. Stove in the January 2022 issue of the Journal of Pharmaceutical and Biomedical Analysis, demonstrated a robust analytical validation of eight …
Read Storyby Neoteryx | 4 min read
Serology research studies play a critical role in advancing our understanding of infectious diseases, and also in developing effective vaccines and therapies. Serological testing of blood samples for research has …
Read Storyby Neoteryx | 3 min read
With advances in healthcare and research, you no longer need to visit the lab for blood draws. Many health and wellness organizations are now providing home health testing kits that …
Read Storyby Neoteryx | 3 min read
A drop or two of blood can reveal a person's genetic make-up and their unique biomarkers. These are clues that can indicate where a person's ancestors came from, and also …
Read Storyby Neoteryx | 4 min read
Why go to the lab or blood draw clinic if you don't have to? Many health and wellness companies now offer home health kits that enable you to collect your …
Read Storyby Neoteryx | 4 min read
When your immune system is strong, it is a powerful warrior that can fight off viruses, bacteria, fungi and other foreign invaders. Many contagions have the potential to infect you …
Read StoryLearn about insights, research, case studies, and tutorials on integrating remote specimen collection, microsampling, and more!
© Neoteryx 2021 | Privacy Policy | Sitemap
421 Amapola Ave
Torrance, CA 90501
This site is protected by reCAPTCHA and the Google Privacy
Policy and Terms of Service apply.
Mitra® devices are intended as a specimen collector and for the storage and transport of biological fluids. They are CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada, Thailand, and Ukraine. In the United States, Mitra devices are for Research Use Only (RUO). In some countries, Mitra devices may be used in clinical diagnostic laboratory systems after the laboratory has validated their complete system in compliance with relevant rules and regulations. Mitra is a registered trademark of Neoteryx, LLC.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use. hemaPEN® is a registered trademark owned by Trajan Scientific Australia Pty Ltd.
Copyright © 2022 Neoteryx, LLC, Part of the Trajan Family. All rights reserved.